PACLITAXELPACLITAXEL (Gland Pharma Limited)
Welcome to the PulseAid listing for the PACLITAXEL drug offered from Gland Pharma Limited. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | paclitaxel |
SUBSTANCE NAME: | PACLITAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-09-30 |
END MARKETING DATE: | 0000-00-00 |
PACLITAXEL PACLITAXEL HUMAN PRESCRIPTION DRUG Details:
Item Description | PACLITAXEL PACLITAXEL from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2016-09-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-178_aeff20f1-c4e7-46c6-a6cb-f0aab334571b |
PRODUCT NDC: | 68083-178 |
APPLICATION NUMBER: | ANDA207326 |
Other PACLITAXEL Pharmaceutical Manufacturers / Labelers: